We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IS
ironSource Ltd.
IS
|
+$136M |
| 2 |
Tesla
TSLA
|
+$119M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
Home Depot
HD
|
+$101M |
| 5 |
Pfizer
PFE
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$247M |
| 2 |
Intel
INTC
|
+$216M |
| 3 |
Ford
F
|
+$145M |
| 4 |
General Motors
GM
|
+$143M |
| 5 |
Micron Technology
MU
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
DNOW Inc
DNOW
$2.44B
| $400K | ﹤0.01% |
46,857
-61,130
| -57% | -$530K |
|
1702
Arcus Biosciences
RCUS
$3.33B
| $400K | ﹤0.01% |
+9,880
| New | +$383K |
|
1703
OFG Bancorp
OFG
$2.21B
| $399K | ﹤0.01% |
15,009
-31,990
| -68% | -$829K |
|
1704
Opendoor
OPEN
$3.54B
| $399K | ﹤0.01% |
+28,200
| New | +$521K |
|
|
ELME
1705
Elme Communities
ELME
$145M
| $398K | ﹤0.01% |
15,380
-35,820
| -70% | -$915K |
|
1706
Imperial Oil
IMO
$62.3B
| $398K | ﹤0.01% |
11,024
| – | – |
|
1707
El Pollo Loco
LOCO
$503M
| $398K | ﹤0.01% |
28,020
-23,380
| -45% | -$342K |
|
1708
PTC Therapeutics
PTCT
$6.18B
| $398K | ﹤0.01% |
10,000
+3,474
| +53% | +$133K |
|
1709
Agilysys
AGYS
$3.21B
| $396K | ﹤0.01% |
8,900
| – | – |
|
|
TPTX
1710
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $396K | ﹤0.01% |
8,310
-7,704
| -48% | -$344K |
|
1711
WIX.com
WIX
$2.56B
| $394K | ﹤0.01% |
2,500
| – | – |
|
1712
World Kinect Corp
WKC
$2.07B
| $392K | ﹤0.01% |
14,801
-40,180
| -73% | -$1.15M |
|
1713
Ichor Holdings
ICHR
$2.17B
| $391K | ﹤0.01% |
8,500
-19,800
| -70% | -$877K |
|
1714
NETSCOUT
NTCT
$2.83B
| $391K | ﹤0.01% |
11,820
-52,140
| -82% | -$1.58M |
|
1715
Rithm Capital
RITM
$5.58B
| $391K | ﹤0.01% |
+36,520
| New | +$407K |
|
|
NVRO
1716
DELISTED
NEVRO CORP.
NVRO
| $390K | ﹤0.01% |
+4,810
| New | +$482K |
|
|
EBIX
1717
DELISTED
Ebix Inc
EBIX
| $390K | ﹤0.01% |
12,824
-9,810
| -43% | -$313K |
|
|
CFLT
1718
DELISTED
Confluent
CFLT
| $389K | ﹤0.01% |
5,100
| – | – |
|
1719
Skywest
SKYW
$4.35B
| $389K | ﹤0.01% |
9,892
-37,360
| -79% | -$1.67M |
|
1720
Algonquin Power & Utilities
AQN
$4.59B
| $382K | ﹤0.01% |
26,435
| – | – |
|
1721
Evolent Health
EVH
$371M
| $382K | ﹤0.01% |
+13,810
| New | +$396K |
|
1722
Northwest Natural Holdings
NWN
$2.15B
| $382K | ﹤0.01% |
7,826
-28,040
| -78% | -$1.3M |
|
|
CHCT
1723
Community Healthcare Trust
CHCT
$536M
| $380K | ﹤0.01% |
8,030
-1,170
| -13% | -$53.7K |
|
1724
OneSpan
OSPN
$584M
| $378K | ﹤0.01% |
22,349
-5,870
| -21% | -$109K |
|
1725
Provident Financial Services
PFS
$3.14B
| $378K | ﹤0.01% |
15,600
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
- Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
- Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
- Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
- Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
- Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
- Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.